Fresenius Medical Care AG (FMCQF) Long-Term Deferred Tax (2016 - 2025)

Fresenius Medical Care AG has reported Long-Term Deferred Tax over the past 17 years, most recently at $275.4 million for Q4 2025.

  • Quarterly results put Long-Term Deferred Tax at $275.4 million for Q4 2025, up 12.27% from a year ago — trailing twelve months through Dec 2025 was $275.4 million (up 12.27% YoY), and the annual figure for FY2025 was $275.4 million, up 12.27%.
  • Long-Term Deferred Tax for Q4 2025 was $275.4 million at Fresenius Medical Care AG, up from $245.3 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for FMCQF hit a ceiling of $360.8 million in Q4 2021 and a floor of $245.3 million in Q4 2024.
  • Median Long-Term Deferred Tax over the past 5 years was $305.5 million (2023), compared with a mean of $301.2 million.
  • Biggest five-year swings in Long-Term Deferred Tax: decreased 19.73% in 2024 and later rose 12.27% in 2025.
  • Fresenius Medical Care AG's Long-Term Deferred Tax stood at $360.8 million in 2021, then fell by 11.57% to $319.0 million in 2022, then dropped by 4.23% to $305.5 million in 2023, then dropped by 19.73% to $245.3 million in 2024, then increased by 12.27% to $275.4 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $275.4 million (Q4 2025), $245.3 million (Q4 2024), and $305.5 million (Q4 2023) per Business Quant data.